# St. Josef-Hospital

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/st-josef-hospital/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 81.3 |
| Citations | 465,139 |
| City | Bochum |
| Country | DE |
| Description | St. Josef-Hospital is a research organisation in Bochum, DE. OpenAlex records 7,126 works and 465,139 citations for it. 1,707 researchers list it as their most recent affiliation. |
| Homepage | https://www.klinikum-bochum.de/st-josef-hospital/standort.html |
| OpenAlex ID | https://openalex.org/I4210138993 |
| Researchers | 1,707 |
| ROR ID | https://ror.org/046vare28 |
| Type | healthcare |
| Works | 7,126 |

## University papers

- [Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study](https://scholariq.org/papers/siponimod-versus-placebo-in-secondary-progressive-multiple-sclerosis-expand-a/)
- [ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis](https://scholariq.org/papers/ectrims-ean-guideline-on-the-pharmacological-treatment-of-people-with-multiple/)
- [Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management](https://scholariq.org/papers/update-on-the-diagnosis-and-treatment-of-neuromyelitis-optica-spectrum-disorders/)
- [DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis](https://scholariq.org/papers/dna-methylation-as-a-mediator-of-hla-drb1-15-01-and-a-protective-variant-in/)
- [Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)](https://scholariq.org/papers/multiple-sclerosis-therapy-consensus-group-mstcg-position-statement-on-disease/)

## University top topics

Showing 8 of 25.

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Genetic Neurodegenerative Diseases](https://scholariq.org/topics/genetic-neurodegenerative-diseases/)
- [Peripheral Neuropathies and Disorders](https://scholariq.org/topics/peripheral-neuropathies-and-disorders/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Neurological disorders and treatments](https://scholariq.org/topics/neurological-disorders-and-treatments/)
- [Pancreatitis Pathology and Treatment](https://scholariq.org/topics/pancreatitis-pathology-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.